Based on these gene expression and immunohistochemistry data, together with the presence of the Cre-mediated recombination product, in two distinct mouse lines, we concluded that NT3-initiated tumor formation is indeed driven by NF-κB activation. The gene discussed is NFKB1; the disease is neoplasm.